End to End CRDMO Platform for Drugs

WuXi TIDES oligonucleotide platform provides comprehensive CRDMO services from drug discovery to commercial manufacturing for both drug substance and drug product.

Our oligonucleotide discovery synthesis services support high throughput library synthesis and custom synthesis (nmol-mmol). We cover all types of oligonucleotides, their monomers, linkers, ligands and conjugates. Additionally, we provide dedicated analytical support for all required testing.

We can seamlessly scale up to any scale (mmol – mol) to meet various demands from preclinical, clinical to commercial stages with ample capacities and proven capabilities with commercial success. Beyond chemistry, we provide formulation development and manufacturing services with various dosage forms and filling formats. These services are coupled with comprehensive analytical support for both API and drug product under one quality system, as well as the integrated CMC dossier preparation services, enabling our customers to bring their oligonucleotide therapeutics to market faster.